Researchers, chemists, healers, advocates, and organizations who shaped the field.
Swiss chemist who first synthesized LSD in 1938 and discovered its psychoactive properties in 1943.
American chemist who synthesized and personally tested hundreds of psychoactive compounds, including popularizing MDMA and creating the 2C-x family.
American author and lay therapist who co-authored PIHKAL and TIHKAL and advocated for MDMA-assisted psychotherapy.
Mazatec healer who shared sacred psilocybin mushroom ceremonies with Westerners, inadvertently launching global interest in psychedelic mushrooms.
American mycologist who popularized the science and potential of fungi through books, talks, and advocacy for psilocybin research.
Founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), which led the effort to develop MDMA-assisted therapy through FDA clinical trials.
Johns Hopkins researcher whose landmark studies on psilocybin reignited mainstream scientific interest in psychedelic therapy.
Harvard psychologist who became the most visible advocate for LSD and psilocybin in the 1960s counterculture, coining the phrase "turn on, tune in, drop out."
Czech-born psychiatrist who conducted pioneering LSD psychotherapy research and later developed holotropic breathwork as a non-drug alternative.
Online archive of information about psychoactive substances, including experience reports, chemistry, health, and law.
Nonprofit promoting health and safety within the nightlife and electronic music community through drug checking services and education.
MAPS-affiliated program providing psychedelic peer support and harm reduction services at festivals and events.
